National Institute of Alcohol Abuse and Alcoholism Director Dr. George Koob will present opening remarks on NIAAA’s liver-related work while Dr. Joe Wang will be in person to present on research opportunities and answer audience questions.

Through applied clinical informatics, electronic health record (EHR) embedded interventions represent an opportunity for enhancing and standardizing care delivery to ensure equitable outcomes. Through utilization of scalable solutions, the field of clinic

This session will review the latest evidence-based recommendations on the safety and This session will review the latest evidence-based recommendations on the safety and efficacy of COVID-19 vaccines in patients with chronic liver disease and liver transp

This session will be a review of common conundrums that are faced by hepatologists. We will hear from experts in the field to hear their management of choice for difficult circumstances.

Artificial Intelligence (AI) technology has revolutionized the way we process, analyze, and interpret complex data in liver research and clinical practice. One of the most promising AI applications is the use of chatbots such as ChatGPT and Midjourney, wh

Implementation Considerations for Expanding Access to Treatment in Different Regions

The goal of this event is to provide an opportunity for leading-edge basic and clinical scientists to engage and interact with the audience on recent advancements in DILI.
The idea is loosely based on NPR’s weekend game show “Wait, Wait, Don’t Tell Me”.

¡Ya no más EHGNA! En nuestra lengua Esteatosis Hepatica es el nuevo término general. Y se crea la nueva nomenclatura Esteatosis Hepática Metabólica (MASLD).  

Memorial Sloan Kettering Cancer Center